“Association between Interleukin-6 Levels, Rituximab Response, and Disease Activity in Patients with Rheumatoid Arthritis” (2025) Al Mustansiriyah Journal of Pharmaceutical Sciences, 25(3), pp. 455–461. doi:10.32947/ajps.v25i3.1225.